DUBLIN, Mar. 29, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Intravascular Warming Systems Market, 2014 - 2025" report to their offering.
The global intravascular warming systems market is expected to reach a value of USD 565.4 million by 2025. Increasing number of surgical procedures is the most significant factor projected to boost the growth of the market during the forecast period. According to the WHO, around 266.2 to 359.5 million surgeries were performed globally in 2012 and this number is expected to increase in the near future. This in turn results in the need for intravascular warming products pre-, intra-, and postoperatively.
Rising adoption of technologically advanced medical devices by operating rooms, ICUs, and emergency rooms is another major factor contributing to the growth of the market. The manufacturers are focusing on developing better in-line intravascular warming systems, which facilitate rapid flow of normothermic blood and intravenous fluids. The portability feature of these product also facilitates convenient usage during trauma or while transporting a patient to the hospital. Thus, the popularity of these devices is growing at a rapid pace, which is expected to propel the growth of the market.
North America held the largest share in the year 2015. The factors that can be attributed to such growth include well-developed healthcare infrastructure and high incidence of hypothermia & related death rates in countries like the U.S.
- Stryker Corporation
- The 37Company
- Smiths Medical, Inc.
- Geratherm Medical AG
- Inditherm Plc
- Becton, Dickinson and Company (BD)
- Estill Medical Technologies, Inc.
Key Topics Covered:
1 Research Methodology
2 Executive Summary
3 Intravascular Warming Systems Market Variables, Trends & Scope
4 Intravascular Warming Systems Market: Application Estimates & Trend Analysis
5 Intravascular Warming Systems Market: End-use Estimates & Trend Analysis
6 Intravascular Warming Systems Market: Regional Estimates & Trend Analysis, by Application and End-use
7 Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/z3prhx/intravascular
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets